DK3303579T3 - Assays til at identificere genetiske elementer, der påvirker fænotype - Google Patents
Assays til at identificere genetiske elementer, der påvirker fænotype Download PDFInfo
- Publication number
- DK3303579T3 DK3303579T3 DK16744892.7T DK16744892T DK3303579T3 DK 3303579 T3 DK3303579 T3 DK 3303579T3 DK 16744892 T DK16744892 T DK 16744892T DK 3303579 T3 DK3303579 T3 DK 3303579T3
- Authority
- DK
- Denmark
- Prior art keywords
- assays
- genetic elements
- identify genetic
- influence phenotype
- phenotype
- Prior art date
Links
- 238000003556 assay Methods 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
- C12N15/1024—In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2014877 | 2015-05-28 | ||
| PCT/NL2016/050381 WO2016190743A1 (en) | 2015-05-28 | 2016-05-27 | Assays to identify genetic elements affecting phenotype |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3303579T3 true DK3303579T3 (da) | 2021-05-31 |
Family
ID=53718102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16744892.7T DK3303579T3 (da) | 2015-05-28 | 2016-05-27 | Assays til at identificere genetiske elementer, der påvirker fænotype |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10351845B2 (da) |
| EP (2) | EP3892724A1 (da) |
| JP (1) | JP6847930B2 (da) |
| CN (1) | CN107922936B (da) |
| AU (1) | AU2016266427B2 (da) |
| CA (1) | CA2987383C (da) |
| DK (1) | DK3303579T3 (da) |
| ES (1) | ES2878185T3 (da) |
| WO (1) | WO2016190743A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3892724A1 (en) | 2015-05-28 | 2021-10-13 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Assays to identify genetic elements affecting phenotype |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| CN109355245A (zh) * | 2018-12-24 | 2019-02-19 | 江南大学 | 一种基于流式细胞术超高通量分离酿酒酵母单倍体的方法 |
| CN116087069B (zh) * | 2023-04-10 | 2023-08-08 | 苏州药明康德新药开发有限公司 | 一种基于流式细胞术检测特定细胞群体组蛋白甲基化和乙酰化修饰水平的方法 |
| WO2025153714A1 (en) | 2024-01-19 | 2025-07-24 | Scenic Biotech Bv | Pla2g15 inhibitors for use in the treatment of lysosomal storage diseases, hiv, alzheimer's disease or parkinson's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101346724B (zh) * | 2005-11-26 | 2018-05-08 | 纳特拉公司 | 清除干扰遗传数据,并使用遗传数据进行预测的方法和体系 |
| EP2396430B1 (en) | 2009-02-16 | 2013-05-01 | Epicentre Technologies Corporation | Template-independent ligation of single-stranded dna |
| JP5886195B2 (ja) | 2009-07-09 | 2016-03-16 | ホワイトヘッド・インスティチュート・フォア・バイオメディカル・リサーチ | 哺乳動物遺伝学のための組成物および方法、ならびにその使用 |
| EA038600B1 (ru) * | 2012-04-02 | 2021-09-21 | Берг Ллк | Основанные на клетках перекрестные анализы и их применение |
| EP3892724A1 (en) | 2015-05-28 | 2021-10-13 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Assays to identify genetic elements affecting phenotype |
-
2016
- 2016-05-27 EP EP21167038.5A patent/EP3892724A1/en not_active Withdrawn
- 2016-05-27 WO PCT/NL2016/050381 patent/WO2016190743A1/en not_active Ceased
- 2016-05-27 EP EP16744892.7A patent/EP3303579B1/en active Active
- 2016-05-27 ES ES16744892T patent/ES2878185T3/es active Active
- 2016-05-27 CN CN201680044096.9A patent/CN107922936B/zh active Active
- 2016-05-27 US US15/577,653 patent/US10351845B2/en active Active
- 2016-05-27 CA CA2987383A patent/CA2987383C/en active Active
- 2016-05-27 AU AU2016266427A patent/AU2016266427B2/en active Active
- 2016-05-27 JP JP2018514768A patent/JP6847930B2/ja active Active
- 2016-05-27 DK DK16744892.7T patent/DK3303579T3/da active
-
2019
- 2019-06-11 US US16/438,102 patent/US20190309287A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2987383C (en) | 2023-10-24 |
| CA2987383A1 (en) | 2016-12-01 |
| EP3303579A1 (en) | 2018-04-11 |
| JP2018525024A (ja) | 2018-09-06 |
| AU2016266427A1 (en) | 2017-12-21 |
| EP3303579B1 (en) | 2021-04-07 |
| ES2878185T3 (es) | 2021-11-18 |
| US20180163197A1 (en) | 2018-06-14 |
| AU2016266427B2 (en) | 2022-01-13 |
| US10351845B2 (en) | 2019-07-16 |
| CN107922936A (zh) | 2018-04-17 |
| US20190309287A1 (en) | 2019-10-10 |
| WO2016190743A1 (en) | 2016-12-01 |
| JP6847930B2 (ja) | 2021-03-24 |
| CN107922936B (zh) | 2021-10-22 |
| EP3892724A1 (en) | 2021-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE056911T2 (hu) | Genetikai konstrukció | |
| MA43259A (fr) | Liants ctla4 | |
| DK3334824T3 (da) | Pd-1-antistoffer | |
| DK3129487T3 (da) | Forbedrede nukleinsyrekonstruktioner til eukaryot genekspression | |
| DK3102722T3 (da) | Genom fraktionering | |
| DK3113883T3 (da) | Cellesorteringssystem der anvender mikrofremstillede komponenter | |
| DK3072835T3 (da) | Fremgangsmåde til fremføring | |
| DK3298718T3 (da) | Teknikker til signal-forlængelsessignalering | |
| EP3327220A4 (en) | BINDING MACHINE | |
| DK3198284T3 (da) | Paletbaserede systemer til analytkarakterisering | |
| DK3125898T3 (da) | Farmakofor til trail-induktion | |
| MA42692A (fr) | Compositions biopharmaceutiques | |
| EP3388526A4 (en) | MICRO BACTERIA | |
| DK3262182T3 (da) | Modificeret creatinase | |
| EP3322963A4 (en) | Diverting checkweigher | |
| EP3327221A4 (en) | BINDING MACHINE | |
| EP3399032A4 (en) | NOVEL BETA GALACTOSIDASE | |
| DK3296597T3 (da) | Krydshovedmotor | |
| EP3341117C0 (en) | Reactor | |
| EP3343641A4 (en) | PHOTO DETECTOR | |
| DK3206535T3 (da) | Ligevægtsledforbindelse | |
| EP3390240A4 (en) | LOADING STRUCTURE | |
| EP3336527A4 (en) | X-ray fluorescence spectrometer | |
| DK3513192T3 (da) | Celledødsbiomarkør | |
| HUE042031T2 (hu) | Csökkentett biuret-tartalmú mûtrágya |